[PTGX] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
27-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 180.15%
YoY- 187.37%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 60,000 0 8,617 5,650 2,719 2,353 11,282 32.10%
PBT 27,335 -34,194 -36,907 -18,886 -16,645 -14,664 -3,052 -
Tax -4,242 -2,909 -832 -1,305 856 -799 -117 81.87%
NP 27,335 -31,285 -36,907 -18,886 -17,501 -13,865 -3,052 -
Tax Rate 15.52% - - - - - - -
Total Cost 32,665 31,285 45,524 24,536 20,220 16,218 14,334 14.70%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 45.56 0.00 -428.30 -334.27 -643.66 -589.25 -27.05 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 0.45 -0.64 -0.77 -0.48 -0.63 -0.57 -0.15 -
EPS Diluted 0.44 -0.64 -0.77 -0.48 -0.63 -0.57 -0.15 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.